SAS vs. SAS vs. Phoenix [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-11-12 13:01  – Posting: # 20788
Views: 1,167

Hi to all victims of the partial replicate with incomplete data,

following extensive off-list discussions with PharmCat (who is working on a [image] Julia-package; see here and there) I checked again what we got with the FDA’s covariance structure, Satterthwaite’s df (PE, 90% CI).
Not the slightest idea how I arrived at the results given above. Sorry for the confusion caused.
In all cases simplifying the covariance structure (in SAS-lingo FA0(1) instead of the FA0(2) in the guidance): Convergence without warning.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
20,237 posts in 4,258 threads, 1,397 registered users;
online 9 (1 registered, 8 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 10:35 CET

Science may set limits to knowledge,
but should not set limits to imagination.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5